Literature DB >> 21556909

The use of MR imaging and spectroscopy of the brain in children investigated for developmental delay: what is the most appropriate imaging strategy?

Paul D Griffiths1, Ruth Batty, Daniel Warren, Anthony Hart, Mark Sharrard, Santosh R Mordekar, Ashok Raghavan, Daniel J A Connolly.   

Abstract

OBJECTIVES: Developmental delay is a common problem in paediatric practice and many children with developmental delay are referred for MR imaging. Our study was performed as part of a continuing audit process to optimise our MR protocol and case selection.
MATERIALS AND METHODS: We performed MR imaging and spectroscopy protocol on 157 children with developmental delay. We analysed the effect of these interventions by looking at the overall detection rate of relevant pathology and in particular subgroups of the children.
RESULTS: 71% of the children had normal MR imaging, 10% had non-specific findings and 19% had specific abnormalities on MR imaging. The overall risk of having a specific structural abnormality with isolated developmental was 7.5% but if other neurological symptoms/signs were present the risk was 28%. Two children had abnormal spectroscopic findings, one with tuberous sclerosis and the other with absent brain creatine.
CONCLUSION: Case selection for MR imaging is important in children with developmental delay. The best strategies for selecting children for MR are either; not performing MR with developmental delay in one domain only or performing MR with developmental delay in three or four domains or if there are other neurological features.

Entities:  

Mesh:

Year:  2011        PMID: 21556909     DOI: 10.1007/s00330-011-2144-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  14 in total

1.  Predictive value of screening for different areas of development.

Authors:  C M Drillien; R M Pickering; M B Drummond
Journal:  Dev Med Child Neurol       Date:  1988-06       Impact factor: 5.449

2.  Developmental delay in children: assessment with proton MR spectroscopy.

Authors:  Christopher G Filippi; Aziz M Uluğ; Michael D F Deck; Robert D Zimmerman; Linda A Heier
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

3.  Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex.

Authors:  W Mukonoweshuro; I D Wilkinson; P D Griffiths
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

4.  White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?

Authors:  Nicolás Fayed; Humberto Morales; Pedro J Modrego; Juan Muñoz-Mingarro
Journal:  Acad Radiol       Date:  2006-02       Impact factor: 3.173

5.  [MRI of the brain in the evaluation of children with developmental delay].

Authors:  Z Bouhadiba; J Dacher; M Monroc; C Vanhulle; J F Ménard; G Kalifa
Journal:  J Radiol       Date:  2000-08

6.  Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.

Authors:  M Shevell; S Ashwal; D Donley; J Flint; M Gingold; D Hirtz; A Majnemer; M Noetzel; R D Sheth
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

7.  Magnetic resonance imaging and proton magnetic resonance spectroscopy of the brain in the diagnostic evaluation of developmental delay.

Authors:  Krijn T Verbruggen; Linda C Meiners; Paul E Sijens; Roelineke J Lunsing; Francjan J van Spronsen; Oebele F Brouwer
Journal:  Eur J Paediatr Neurol       Date:  2008-06-24       Impact factor: 3.140

8.  Proton MR spectroscopy of polymicrogyria and heterotopia.

Authors:  Elysa Widjaja; Paul D Griffiths; Iain D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

9.  Myelination as assessed by conventional MR imaging is normal in young children with idiopathic developmental delay.

Authors:  S M Maricich; P Azizi; J Y Jones; M C Morriss; J V Hunter; E O Smith; G Miller
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

10.  Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study.

Authors:  M C Bianchi; M Tosetti; R Battini; V Leuzzi; M G Alessandri'; C Carducci; I Antonozzi; G Cioni
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

View more
  2 in total

Review 1.  Current evidence-based recommendations on investigating children with global developmental delay.

Authors:  Renuka Mithyantha; Rachel Kneen; Emma McCann; Melissa Gladstone
Journal:  Arch Dis Child       Date:  2017-11       Impact factor: 3.791

2.  Accuracy of in-utero MRI to detect fetal brain abnormalities and prognosticate developmental outcome: postnatal follow-up of the MERIDIAN cohort.

Authors:  Anthony R Hart; Nicholas D Embleton; Michael Bradburn; Daniel J A Connolly; Laura Mandefield; Cara Mooney; Paul D Griffiths
Journal:  Lancet Child Adolesc Health       Date:  2019-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.